Table 8 Comparison between serum and BAL miRNA for diagnosis of lung cancer
From: MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients
| Â | Serum miRNA | BAL miRNA |
|---|---|---|
Sensitivity | 91.9% | 94.6% |
Specificity | 93.3% | 96.6% |
PPV | 94.4% | 97.2% |
NPV | 90.3% | 93.5% |
Accuracy | 92.5% | 95.5% |